Business Description
Chemo Pharma Laboratories Ltd
NAICS : 325412
ISIN : INE320M01019
Compare
Compare
Traded in other countries / regions
506365.India IPO Date
2011-10-10Description
Chemo Pharma Laboratories Ltd is a pharmaceutical company. Currently, the company is not engaged in any business activity.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 1 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -42.8 | |||||
| 3-Year EPS without NRI Growth Rate | -10.6 | |||||
| 3-Year Book Growth Rate | 2.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 83.72 | |||||
| 9-Day RSI | 76.04 | |||||
| 14-Day RSI | 69.06 | |||||
| 6-1 Month Momentum % | 88.9 | |||||
| 12-1 Month Momentum % | 56.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 444.93 | |||||
| Quick Ratio | 444.93 | |||||
| Cash Ratio | 439.88 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | 8.15 | |||||
| ROA % | 8.12 | |||||
| ROIC % | -0.86 | |||||
| ROC (Joel Greenblatt) % | 1577.91 | |||||
| ROCE % | 8.46 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.37 | |||||
| PE Ratio without NRI | 9.48 | |||||
| Shiller PE Ratio | 14.46 | |||||
| PB Ratio | 0.96 | |||||
| Price-to-Tangible-Book | 1 | |||||
| EV-to-EBIT | 6.11 | |||||
| EV-to-EBITDA | 6.07 | |||||
| EV-to-FCF | -8.31 | |||||
| Price-to-Projected-FCF | 0.96 | |||||
| Price-to-Graham-Number | 0.66 | |||||
| Price-to-Net-Current-Asset-Value | 1.96 | |||||
| Price-to-Net-Cash | 1.98 | |||||
| Earnings Yield (Greenblatt) % | 16.36 | |||||
| FCF Yield % | -5.49 | |||||
| Forward Rate of Return (Yacktman) % | -29.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chemo Pharma Laboratories Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | |||
| EPS (TTM) (₹) | 6.453 | ||
| Beta | -0.54 | ||
| Volatility % | 81.22 | ||
| 14-Day RSI | 69.06 | ||
| 14-Day ATR (₹) | 4.302826 | ||
| 20-Day SMA (₹) | 69.969 | ||
| 12-1 Month Momentum % | 56.21 | ||
| 52-Week Range (₹) | 27.17 - 87 | ||
| Shares Outstanding (Mil) | 1.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chemo Pharma Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chemo Pharma Laboratories Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chemo Pharma Laboratories Ltd Frequently Asked Questions
What is Chemo Pharma Laboratories Ltd(BOM:506365)'s stock price today?
The current price of BOM:506365 is ₹82.90. The 52 week high of BOM:506365 is ₹87.00 and 52 week low is ₹27.17.
When is next earnings date of Chemo Pharma Laboratories Ltd(BOM:506365)?
The next earnings date of Chemo Pharma Laboratories Ltd(BOM:506365) is .
Does Chemo Pharma Laboratories Ltd(BOM:506365) pay dividends? If so, how much?
Chemo Pharma Laboratories Ltd(BOM:506365) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers